Not approved in Canada · No submission under review

See the timeline
RetatrutideCanada Check the status

Editorial policy

Retatrutide Canada exists to answer one question accurately: where does this drug stand for people in Canada? These are the rules we hold ourselves to. Last updated October 5, 2026.

Where our information comes from

We rank sources, and we say which kind each claim rests on.

Dates on everything

Each page shows the day it was last checked against its sources. Each event on the approval timeline has its own date and its own link. A step that has not happened carries no date, even when a company has named a target window. We print the window in words and leave the date blank.

What we will not publish

Medical review

Pages that make clinical claims, such as side effects and dosing, need review by a licensed Canadian pharmacist. Until that review has happened, the page carries a visible notice saying it is awaiting one. When it has, the reviewer's name, credential and review date appear on the page.

Independence and funding

This site has no affiliation with Eli Lilly and Company and takes no money from any drug manufacturer. It sells nothing and carries no affiliate links to sellers of retatrutide.

Corrections

If a regulator, a journal or a company publishes something that changes a fact here, we update the page and its check date. If we got something wrong, we fix it and say what changed.

See also our medical disclaimer.